RE: Meta-analysis of the efficacy and safety of mirabegron and solifenacin monotherapy for overactive bladder

被引：0
|
作者：
Zhou, Zhongbao [1 ,2 ]
Gao, Zhenli [2 ]
机构：
[1] Binzhou Med Univ, Yantai, Shandong, Peoples R China
[2] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Urol, 20 East Yuhuangding Rd, Yantai 264000, Shandong, Peoples R China
来源：
NEUROUROLOGY AND URODYNAMICS | 2019年 / 38卷 / 06期
关键词：
D O I：
10.1002/nau.24049
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1792 / 1792
页数：1
相关论文
共 50 条
  • [21] THERAPEUTIC EFFICACY AND SAFETY OF MIRABEGRON MONOTHERAPY IN MALE OVERACTIVE BLADDER PATIENTS WITH AND WITHOUT BLADDER OUTLET OBSTRUCTION
    Liao, C.
    Lee, C.
    Lee, Y.
    Kuo, H.
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 : S80 - S82
  • [22] The Role of Mirabegron in Overactive Bladder: A Systematic Review and Meta-Analysis
    Wu, Tao
    Duan, Xi
    Cao, Chen-Xi
    Peng, Chuan-Du
    Bu, Si-Yuan
    Wang, Kun-Jie
    UROLOGIA INTERNATIONALIS, 2014, 93 (03) : 326 - 337
  • [23] Mirabegron and Anticholinergics in the Treatment of Overactive Bladder Syndrome: A Meta-analysis
    Sartori, Luisa Gracio Ferreira
    Nunes, Bruno Monteiro
    Farah, Daniela
    de Oliveira, Leticia Maria
    Novoa, Claudia Cristina Takano
    Sartori, Marair Gracio Ferreira
    Fonseca, Marcelo Cunio Machado
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2023, 45 (06): : 337 - 346
  • [24] SAFETY AND EFFICACY OF MIRABEGRON ADD-ON TREATMENT TO SOLIFENACIN IN OAB SUBJECTS IN COMPARISON TO SOLIFENCIN MONOTHERAPY: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Naser, O.
    Elgebaly, A.
    Menshawy, A.
    Kamal, Y.
    Negida, A.
    Gana, B.
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 : S206 - S207
  • [25] The Efficacy and Safety of Solifenacin in Patients with Overactive Bladder Syndrome
    Oreskovic, Slavko
    But, Igor
    Banovic, Maja
    Goldstajn, Marina Sprem
    COLLEGIUM ANTROPOLOGICUM, 2012, 36 (01) : 243 - 248
  • [26] Mirabegron as Add-On Treatment to Solifenacin in Patients with Incontinent Overactive Bladder and an Inadequate Response to Solifenacin Monotherapy EDITORIAL COMMENT
    Chughtai, Bilal
    JOURNAL OF UROLOGY, 2016, 196 (03): : 818 - 818
  • [27] Mirabegron in Overactive Bladder: A Review of Efficacy, Safety, and Tolerability
    Chapple, Christopher R.
    Cardozo, Linda
    Nitti, Victor W.
    Siddiqui, Emad
    Michel, Martin C.
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (01) : 17 - 30
  • [28] Re: Efficacy and Safety of Mirabegron in Men with Overactive Bladder Symptoms and Benign Prostatic Hyperplasia
    不详
    JOURNAL OF UROLOGY, 2021, 206 (04): : 1067 - 1067
  • [29] Efficacy and tolerability of mirabegron compared with solifenacin for children with idiopathic overactive bladder: A preliminary study
    Kim, Seong Cheol
    Park, Myungchan
    Chae, Chongsok
    Yoon, Ji Hyung
    Kwon, Taekmin
    Park, Sejun
    Moon, Kyung Hyun
    Cheon, Sang Hyeon
    Park, Sungchan
    INVESTIGATIVE AND CLINICAL UROLOGY, 2021, 62 (03) : 317 - 323
  • [30] Monotherapy with mirabegron had a better tolerance than the anticholinergic agents on overactive bladder A systematic review and meta-analysis
    Yi, Wei
    Yang, Yue
    Yang, Jin
    MEDICINE, 2021, 100 (41) : E27469
12345